Immupharma PLC Voted Best Medical Research & Development Company
July 11 2012 - 2:00AM
RNS Non-Regulatory
TIDMIMM
Immupharma PLC
11 July 2012
FOR IMMEDIATE RELEASE 11 July 2012
RNS REACH
ImmuPharma PLC
Voted Best Medical Research and Development Company, Europe
2012
ImmuPharma PLC (LSE: IMM) ("ImmuPharma" or the "Company"), the
specialist discovery and development pharmaceutical company, has
been voted "Best Medical Research and Development Company, Europe"
at The New Economy Pharmaceutical & Healthcare Awards 2012.
This is the second time ImmuPharma has won this prestigious
award, the first being in 2010 when voted "Best Drug Development
Company, Europe".
The Awards have today been published in the Summer edition of
"The New Economy", viewable online at
www.theneweconomy.com/awards/healthcare-awards-2012.
To view the interview with Dimitri Dimitriou, Chief Executive
Officer of ImmuPharma, please go to the "Investors Page" of
ImmuPharma's website (www.immupharma.com) where you will see the
link under "Interviews".
For further information please contact:
ImmuPharma PLC
Dimitri Dimitriou, Chief Executive
Officer +44 20 7152 4080
Lisa Baderoon, Head of Investor
Relations +44 7721 413 496
Buchanan + 44 20 7466 5000
Mark Court
Notes to Editors
ImmuPharma is focusing on developing novel medicines with high
sales potential in specialist markets with serious unmet need.
ImmuPharma has five drug candidates in development, two platform
technologies and approximately 70 patents. The Company's most
advanced drug candidate, Lupuzor(TM) a potential blockbuster drug
for Lupus, a chronic autoimmune disease has recently received the
approval from the US FDA to enter phase III with a Special Protocol
Assessment and "Fast Track" designation. ImmuPharma was founded and
is led by a commercially focused Board and management team with
extensive experience. www.immupharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRASFAFMSFESESW
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024
